Please use this identifier to cite or link to this item:
Type: Conference paper
Title: Detection of low level nilotinib or dasatinib resistant BCR-ABL mutations by mass spectrometry in CML patients who fail Imatinib is highly predivtive of their subsequent clonal expansion when treated with the drug for which their mutation confers resistance
Author: Parker, W.
Ho, M.
Lawrence, R.
Irwin, D.
Scott, H.
Hughes, T.
Branford, S.
Citation: Proceedings of 2010 american society of hematology meeting, 2010
Issue Date: 2010
ISSN: 0006-4971
Conference Name: American Society of Hematology Meeting (52nd : 2010 : Florida, CA.)
Statement of
Wendy T Parker, Musei Ho, Rebecca M Lawrence, Darryl L Irwin, Hamish S Scott, Timothy Hughes and Susan Branford
Rights: Copyright status unknown
RMID: 0020103016
Description (link):
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.